Eli Lilly’s stock slipped 4% in premarket trading Monday after a study published in the scientific journal JAMA found patients on its weight loss drug regained “substantial” weight after stopping treatment.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,